Ping An Healthcare and Technology Co Ltd banner

Ping An Healthcare and Technology Co Ltd
HKEX:1833

Watchlist Manager
Ping An Healthcare and Technology Co Ltd Logo
Ping An Healthcare and Technology Co Ltd
HKEX:1833
Watchlist
Price: 7.87 HKD 5.35% Market Closed
Market Cap: HK$17B

Wall St Price Targets

Price Targets Summary
Ping An Healthcare and Technology Co Ltd

Wall Street analysts forecast Ping An Healthcare and Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ping An Healthcare and Technology Co Ltd is 15.85 HKD with a low forecast of 9.49 HKD and a high forecast of 25.07 HKD.

Lowest Forecast
Price Target
9.49 HKD
21% Upside
Average Forecast
Price Target
15.85 HKD
101% Upside
Highest Forecast
Price Target
25.07 HKD
219% Upside
Ping An Healthcare and Technology Co Ltd Competitors:
Price Targets
MLSS
Milestone Scientific Inc
171% Upside
TOST
Toast Inc
5% Upside
ACCON
Acconeer AB
-60% Downside

Revenue
Forecast

28% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
28% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 11%.

Gross Profit
Forecast

24% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
24% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 8 years is 11%.

Operating Income
Forecast

N/A
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 40%.

Pre-Tax Income
Forecast

N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 31%.

Net Income
Forecast

N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Ping An Healthcare and Technology Co Ltd's stock price target?
Price Target
15.85 HKD

According to Wall Street analysts, the average 1-year price target for Ping An Healthcare and Technology Co Ltd is 15.85 HKD with a low forecast of 9.49 HKD and a high forecast of 25.07 HKD.

What is the Revenue forecast for Ping An Healthcare and Technology Co Ltd?
Projected CAGR
11%

Over the last 9 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 11%.

What is the Gross Profit forecast for Ping An Healthcare and Technology Co Ltd?
Projected CAGR
11%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 8 years is 11%.

What is the Operating Income forecast for Ping An Healthcare and Technology Co Ltd?
Projected CAGR
40%

The compound annual growth rate for Operating Income over the next 8 years is 40%.

What is the Pre-Tax Income forecast for Ping An Healthcare and Technology Co Ltd?
Projected CAGR
31%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 31%.

What is the Net Income forecast for Ping An Healthcare and Technology Co Ltd?
Projected CAGR
16%

The compound annual growth rate for Net Income over the next 8 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett